Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Gastroenterology & hepatologyPRM 2152
Dosage formHard-gelatin capsules
Oral

Acetylcysteine 200 mg, Calcium Pantothenate 10 mg, L-Ornithine + L-Aspartate 150 mg, Niacinamide 50 mg, Silymarin 70 mg, Vitamin B1 5 mg, Vitamin B12 15 mcg, Vitamin B2 5 mg, Vitamin B6 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Mucolytic & expectorant
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 0065
Dosage formTablets
Oral

Acotiamide 100 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gastrointestinal agent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 388
Gastroenterology & hepatologyPRM 2605
Dosage formTablets
Oral

Acotiamide 300 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gastrointestinal prokinetic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 2606
Dosage formTablets
Oral

Acotiamide Hcl Hydrate 300 mg (ER)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gastrointestinal prokinetic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 4629
Dosage formHard-gelatin capsules
Oral

Activated Charcoal 250 mg, Simethicone 80 mg

Same composition also available as

Tablets

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gastrointestinal agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 0066
Dosage formTablets
Oral

Activated Charcoal 250 mg, Simethicone 80 mg

Same composition also available as

Hard-gelatin capsules

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gastrointestinal agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 2608
Dosage formTablets
Oral

Activated Charcoal 50 mg, Ginger Oleoresin 2 mg, Ox Bile Extract 50 mg, Pancreatin 170 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Activated charcoal adsorbent + Digestive enzyme
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 2609
Dosage formTablets
Oral

Activated Charcoal 75 mg, Activated Dimethicone 50 mg, Fungal Diastase (1:800) 20 mg, Niacinamide 25 mg, Papain 30 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Activated charcoal adsorbent + Digestive enzyme + Antiflatulent + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5418
Dosage formOral suspension
Oral

Activated Dimethicone (Simethicone) 50 mg, Aluminium Hydroxide 191.25 mg, Magnesium Hydroxide 250 mg / 10 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Antacid + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5179
Dosage formSyrup
Oral

Activated Dimethicone 125 mg, Aluminium Hydroxide Paste 300 mg, Magnesium Hydroxide Paste 200 mg, Sorbitol Solution 750 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Antacid + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 2610
Dosage formTablets
Oral

Activated Dimethicone 125 mg, Domperidone 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gastrointestinal prokinetic + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5419
Dosage formOral suspension
Oral

Activated Dimethicone 20 mg, Calcium Carbonate 125 mg, Dried Aluminium Hydroxide Gel 100 mg, Magnesium Hydroxide 100 mg, Sodium Bicarbonate 125 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Antacid + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 2611
Dosage formTablets
Oral

Activated Dimethicone 25 mg, Dicyclomine 10 mg, Magaldrate 400 mg, Oxetacaine 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Antacid + Gastrointestinal antispasmodic + Local anaesthetic + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5420
Dosage formOral suspension
Oral

Activated Dimethicone 25 mg, Dicyclomine Hcl 5 mg, Magaldrate 300 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Antacid + Gastrointestinal antispasmodic + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5421
Dosage formOral suspension
Oral

Activated Dimethicone 25 mg, Dried Aluminium Hydroxide Gel 200 mg, Magnesium Hydroxide 200 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Antacid + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5422
Dosage formOral suspension
Oral

Activated Dimethicone 25 mg, Magaldrate 250 mg, Magnesium Carbonate 20 mg, Sodium Alginate 50 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Alginate reflux suppressant + Antacid + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 0068
Dosage formTablets
Oral

Activated Dimethicone 40 mg, Bile Constituents 25 mg, Pancreatin 192 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gastrointestinal agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5423
Dosage formOral suspension
Oral

Activated Dimethicone 40 mg, Dicyclomine Hcl 10 mg / ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Gastrointestinal antispasmodic + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5424
Dosage formOral suspension
Oral

Activated Dimethicone 40 mg, Dicyclomine Hcl 10 mg, Domperidone Maleate 5 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Gastrointestinal antispasmodic + Gastrointestinal prokinetic + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5425
Dosage formOral suspension
Oral

Activated Dimethicone 40 mg, Dried Aluminium Hydroxide 300 mg, Magnesium Hydroxide 250 mg, Sorbitol Solution 1000 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Antacid + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5426
Dosage formOral suspension
Oral

Activated Dimethicone 40 mg, Dried Aluminium Hydroxide Gel 300 mg, Magnesium Hydroxide 250 mg, Oxetacaine 10 mg, Sorbitol Solution 1000 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Antacid + Local anaesthetic + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 2612
Dosage formTablets
Oral

Activated Dimethicone 50 mg, Aluminium Hydroxide 300 mg, Lignocaine 50 mg, Magnesium Hydroxide 100 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Antacid + Local anaesthetic + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 5427
Dosage formOral suspension
Oral

Activated Dimethicone 50 mg, Aluminium Hydroxide 300 mg, Lignocaine 50 mg, Magnesium Hydroxide 100 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Antacid + Local anaesthetic + Antiflatulent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Gastroenterology & hepatologyPRM 0069
Dosage formTablets
Oral

Activated Dimethicone 50 mg, Charcoal 50 mg, Pancreatin 175 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gastrointestinal agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product